Study of Taxane/Carboplatin +/- Cetuximab as First-Line Treatment for Patients With Advanced/Metastatic Non-Small Cell Lung Cancer

PHASE3CompletedINTERVENTIONAL
Enrollment

755

Participants

Timeline

Start Date

December 31, 2004

Primary Completion Date

April 30, 2007

Study Completion Date

August 31, 2008

Conditions
Non-Small-Cell Lung Carcinoma
Interventions
DRUG

Paclitaxel (Taxane)

IV, 225 mg/m\^2

DRUG

Docetaxel (Taxane)

IV, 75 mg/m\^2

DRUG

Carboplatin

AUC=6, q 3 weeks (6 cycles maximum)

DRUG

Cetuximab

Intravenous, 400 mg/m\^2, initial dose followed by 250 mg/m\^2, weekly starting on Week 2

Trial Locations (124)

Unknown

Local Institution, Birmingham

Local Institution, Mobile

Local Institution, Anchorage

Local Institution, Tucson

Local Institution, Springdale

Local Institution, Anaheim

Local Institution, Bakersfield

Local Institution, Concord

Local Institution, Fountain Valley

Local Institution, Gilroy

Local Institution, Long Beach

Local Institution, Los Angeles

Local Institution, Montebello

Local Institution, Oxnard

Local Institution, Rancho Mirage

Local Institution, San Diego

Local Institution, Stockton

Local Institution, Vista

Local Institution, Lakewood

Local Institution, Binghamton

Local Institution, Hartford

Local Institution, New London

Local Institution, Norwich

Local Institution, Stamford

Local Institution, Waterbury

Local Institution, Washington D.C.

Local Institution, Boca Raton

Local Institution, Boynton Beach

Local Institution, Fort Lauderdale

Local Institution, Fort Myers

Local Institution, Inverness

Local Institution, Jacksonville

Local Institution, Lakeland

Local Institution, Lecanto

Local Institution, Pembroke Pines

Local Institution, Port Saint Lucie

Local Institution, Tamarac

Local Institution, Tampa

Local Institution, Augusta

Local Institution, Columbus

Local Institution, Marietta

Local Institution, Honolulu

Local Institution, Evanston

Local Institution, Joliet

Local Institution, Naperville

Local Institution, Normal

Local Institution, Skokie

Local Institution, Fort Wayne

Local Institution, Muncie

Local Institution, New Albany

Local Institution, Terre Haute

Local Institution, Vincennes

Local Institution, Wichita

Local Institution, Hazard

Local Institution, Paducah

Local Institution, Annapolis

Local Institution, Baltimore

Local Institution, Westminster

Local Institution, Boston

Local Institution, Brockton

Local Institution, Flint

Local Institution, Free Soil

Local Institution, Grand Rapids

Local Institution, Jackson

Local Institution, Dulluth

Local Institution, Minneapolis

Local Institution, Saint Louis Park

Local Institution, Jackson

Local Institution, Columbia

Local Institution, Jefferson City

Local Institution, Dover

Local Institution, Newark

Local Institution, Cooperstown

Local Institution, New City

Local Institution, New Rochelle

Local Institution, Northport

Local Institution, Rochester

Local Institution, The Bronx

Local Institution, Valhalla

Local Institution, Burlington

Local Institution, Charlotte

Local Institution, Gastonia

Local Institution, Greensboro

Local Institution, Greenville

Local Institution, Hickory

Local Institution, Morganton

Local Institution, Wilmington

Local Institution, Winston-Salem

Local Institution, Bismarck

Local Institution, Canton

Local Institution, Cincinnati

Local Institution, Cleveland

Local Institution, Columbus

Local Institution, Dayton

Local Institution, Oklahoma City

Local Institution, Bethlehem

Local Institution, Dunmore

Local Institution, Harrisburg

Local Institution, Philadelphia

Local Institution, Pottstown

Local Institution, Sayre

Local Institution, West Reading

Local Institution, Providence

Local Institution, Charleston

Local Institution, Columbia

Local Institution, Mt. Pleasant

Local Institution, Spartanburg

Local Institution, Sumter

Local Institution, Chattanooga

Local Institution, Collierville

Local Institution, Cookeville

Local Institution, Amarillo

Local Institution, Dallas

Local Institution, Houston

Local Institution, Lubbock

Local Institution, Danville

Local Institution, Lynchburg

Local Institution, Richmond

Local Institution, Everett

Local Institution, Lacey

Local Institution, Tacoma

Local Institution, Huntington

Local Institution, La Crosse

Local Institution, Madison

All Listed Sponsors
lead

Eli Lilly and Company

INDUSTRY

NCT00112294 - Study of Taxane/Carboplatin +/- Cetuximab as First-Line Treatment for Patients With Advanced/Metastatic Non-Small Cell Lung Cancer | Biotech Hunter | Biotech Hunter